Loading company…
Smedo develops non-contact technology for measuring vital signs.
Founded in 2019 and based in Brandenburg, Smedo develops devices for non-contact monitoring of vital signs, including heart rate, heart rate variability, and respiratory variability. In April 2022, the company raised EUR 1.66 million in seed funding from Apex Ventures and Brandenburg Kapital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in